| Systematic (IUPAC) name | |
|---|---|
| methyl (2R)-2-(3,4-dichlorophenyl)-2-[(2R)-piperidin-2-yl]acetate | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Unscheduled |
| Routes | Oral |
| Identifiers | |
| ATC code | None |
| PubChem | CID 44296390 |
| ChemSpider | 23104857 |
| Chemical data | |
| Formula | C14H17Cl2NO2 |
| Mol. mass | 302.196 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
threo-3,4-Dichloromethylphenidate (3,4-CTMP) is a stimulant drug related to methylphenidate. It is around 7x more potent than methylphenidate in animal studies, but has weaker reinforcing effects due to its slower onset of action.[1][2][3][4][5] However, H. M. Deutsch's discrimination ratio implies it to be more addictive than even cocaine.[6]
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)